— Know what they know.
Not Investment Advice

IME.AX ASX

ImExHS Limited
1W: +16.1% 1M: -7.1% 3M: -7.1% YTD: -27.8% 1Y: +44.4% 3Y: -48.8% 5Y: -77.4%
A$0.33 ($0.23)
+0.00 (+0.00%)
 
ASX · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 48 · A$17.7M mcap · 52M float · 0.014% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market CapA$17.7M ($12.3M)
52W Range0.23-0.47
Volume23,000
Avg Volume7,215
Beta0.81
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOGerman Arango
Employees290
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2005-12-12
Websiteimexhs.com
32 Martin Place
Sydney, NSW 2020
AU
61 2 9030 0040
About ImExHS Limited

ImExHS Limited delivers cloud-powered medical imaging technologies to customers worldwide, including those in Australia. The firm specializes in the development and sale of modular imaging software systems, which encompass comprehensive information management platforms for disciplines such as radiology, cardiology, and pathology, alongside a robust picture archiving and communication system (PACS). Its principal software solutions include AQUILA for radiology, ALULA for pathology, and Antero for cardiology. Moreover, ImExHS offers STELLA.I, a suite of artificial intelligence tools hosted in the cloud, crafted to bolster diagnostic capabilities for medical professionals. The company further extends outsourced radiology and teleradiology services to hospitals and various other healthcare entities. Established in 2001, ImExHS Limited operates from its base in Mascot, Australia.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms